
Urmi Naik
@urminaik
I lead APAC medical affairs strategy, access, launches, and evidence generation.
What I'm looking for
At Farmamondo, I directed regional medical strategy across autoimmune disease, oncology, rare disease, dermatology, and ophthalmology for Southeast Asia and emerging markets. I aligned scientific and commercial priorities across more than six country teams.
I secured Singapore Chronic Disease List inclusion for key oncology molecules, expanding subsidized access for hundreds of patients annually. I also built partnerships with rare-disease advocacy organizations and led clinical trial collaborations with NUH and KKH.
Previously at Servier, Novartis, Eisai, and Emcure, I drove oncology and ophthalmology launches, regulatory approvals, lifecycle planning, medical education, and advisory boards. I led MSL teams, developed scientific training programs, and supported Phase IV and post-marketing studies.
I'm an MD in Pharmacology who translates scientific evidence into access, medical, and commercial strategies that improve patient outcomes. I bring APAC experience across oncology, cardiology, autoimmune disease, rare disease, and ophthalmology.
Experience
Work history, roles, and key accomplishments
Regional Medical Affairs & Access Manager
Farmamondo Pte. Ltd.
Aug 2022 - Dec 2024 (2 years 4 months)
Directed regional medical strategy across 5 therapeutic areas for Southeast Asia and emerging markets, securing inclusion of oncology molecules in the Singapore Chronic Disease List and building KOL networks.
Medical Lead – Oncology & Cardiology
Servier Pharmaceuticals
Jul 2019 - Dec 2021 (2 years 5 months)
Drove regulatory approvals for oncology assets, managed a portfolio of critical molecules, led MSL teams, and pioneered digital platforms for HCP engagement.
Medical Advisor – Retina (Lucentis)
Novartis Healthcare Pvt. Ltd.
Mar 2018 - Mar 2019 (1 year)
Led medical strategy for Ranibizumab in a competitive biosimilar market, spearheaded launch readiness for Brolucizumab, and managed clinical trials and MSL team development.
Medical Advisor – Oncology
Eisai Pharmaceuticals India Pvt. Ltd.
Jan 2017 - Mar 2018 (1 year 2 months)
Led launch readiness for Lenvatinib in HCC, orchestrated advisory boards, developed HCP education programs, and managed Phase IV studies and pharmacovigilance.
Medical Advisor – Oncology
Emcure Pharmaceuticals Ltd.
Feb 2017 - Sep 2017 (7 months)
Provided medical affairs support for innovator and co-marketed oncology molecules, including scientific content development and advisory board facilitation.
Post-Graduate Lecturer – Department of Pharmacology
MGM Institute of Health Sciences
Sep 2013 - Sep 2016 (3 years)
Delivered pharmacology instruction to medical students and conducted clinical research activities and GCP-compliant studies.
Education
Degrees, certifications, and relevant coursework
Mahatma Gandhi Mission Medical College, Mumbai University
MD, Pharmacology
2013 - 2016
Pursued MD in Pharmacology, focusing on advanced pharmacological sciences and clinical research.
PDVVPF's Medical College, Maharashtra
MBBS, Medicine
2005 - 2010
Completed MBBS, gaining foundational medical knowledge and clinical skills.
Tech stack
Software and tools used professionally
Availability
Location
Authorized to work in
Salary expectations
Job categories
Skills
Interested in hiring Urmi?
You can contact Urmi and 90k+ other talented remote workers on Himalayas.
Message UrmiGet matched with your dream remote job
Sign up now and join over 250,000+ remote workers who receive personalized job alerts, curated job matches, and more for free!
